SUH CAROL Y. enters NEUMORA THERAPEUTICS, INC. with 289.67K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 9/14/2023ACC: 0000899243-23-019078
Officer· Chief Operating Officer
Since Sep 2023
289.67K
Baseline shares
100% direct
289.67K
Direct ownership
1 position
494.13K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned289.67K
Total
289.67K direct289.67K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 289.67K | Direct |
| Total | 289.67K | 289.67K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
82.84K
Shares owned
N/A
Exercise price
6.36
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
123.47K
Shares owned
N/A
Exercise price
4.63
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
280.39K
Shares owned
N/A
Exercise price
6.52
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
7.43K
Shares owned
N/A
Exercise price
2.52
Expiration
—
Exercise window
—
Total
Underlying
494.13K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 6.36 | — | — | 82.84K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 4.63 | — | — | 123.47K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 6.52 | — | — | 280.39K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 2.52 | — | — | 7.43K | N/A |
| Total | 494.13K | 0.00 | ||||